Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
-ELISA-NBP2-61910-img0005.jpg "Lambda Light Chain Antibody (RM110) (NBP2-61910): Novus Biologicals")
Lambda Light Chain Antibody (RM110) (NBP2-61910): Novus Biologicals
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
A universal reference interval for serum immunoglobulins free light chains may be outdated
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment - ScienceDirect
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Validation of serum free light chain reference ranges in primary care - Luca Galvani, Jane Flanagan, Mansour Sargazi, William D Neithercut, 2016
Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment - ScienceDirect
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
What has a scrubbing brush got to do with multiple sclerosis?
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
KAPPA and LAMBDA assays, in serum and urine, for nephelometers and clinical chemistry analyzers - Clinical Laboratory int.
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
